Skip to main content

Burckhardt Compression supports the decarbonization of aviation fuels securing a new order for SkyNRG’s first sustainable aviation fuel production facility

Burckhardt Compression, a global leader in reciprocating compressors and compressor systems, has secured an order from Technip Energies for the delivery of seven compressors for SkyNRG’s first dedicated sustainable aviation fuel (SAF) production facility, DSL-01, in Delfzijl, the Netherlands. The project marks a significant step in advancing the decarbonization of air travel in Europe and beyond. The facility is SkyNRG’s first SAF production plant and the first greenfield facility in Europe designed exclusively for SAF production, without co-processing renewable diesel or other fuels. The plant is expected to produce 100’000 tons of SAF annually.  Burckhardt Compression’s API 618 reciprocating process gas compressors will play a critical role in the plant’s operations, supporting key process steps and enabling safe, reliable, and...

Continue reading

OVH Groupe enters into exclusive negotiations to acquire Gladia, expert in voice AI

Roubaix – June 11th, 2026 – OVH Groupe, a sovereign, global player and European leader in Cloud and AI, announces that it is entering into exclusive negotiations to acquire Gladia, the expert in AI speech-to-text (STT). This transaction aims to strengthen OVH Groupe’s expertise in multimodal and agentic generative AI.                  GladiaFounded in 2022 in Paris, Gladia is a French AI startup specializing in transcription and audio intelligence. Through a single API, the platform transcribes conversations in real time and in batch across more than 100 languages, turning audio data into structured, actionable information. Gladia today supports more than 300,000 developers and 2,000 enterprise customers, including HeyGen, Livestorm, Attention, Circleback, Method Financial, Recall.ai, and Leexi. Through this acquisition, OVH Groupe...

Continue reading

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

– Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 – Azora’s oral candidate, AT177, is a novel, colon‑targeted AhR agonist rationally engineered to have minimal systemic exposure and designed to mitigate safety concerns with systemically absorbed AhR agonists – $32 million in upfront financing with the potential to receive an additional $32 million under additional milestone tranches – Adial to host a conference call today, June 11, 2026 at 1pm ET GLEN ALLEN, Va. and LOS ANGELES, June 11, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that it has acquired Azora Therapeutics, Inc. (“Azora”),...

Continue reading

Yukon Metals Closes C$13 Million Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES/ VANCOUVER, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company”) is pleased to announce that it has completed its previously announced “best efforts” agency based private placement, consisting of (i) 6,885,964 “flow-through” units of the Company (the “FT Units”) at a price of C$0.57 per FT Unit, and (ii) 18,050,000 units of the Company (the “HD Units”) at a price of $0.50 per HD Unit, for aggregate gross proceeds of approximately C$13 million (the “Offering”). The FT Units and the HD Units are collectively referred to herein as the “Offered Securities”. Each Offered Security consists of one...

Continue reading

Top Aces to Acquire Select Global International, Strengthening Canada’s Sovereign Fighter Pilot Training Capability

Advancing Canadian‑Led Live‑Virtual‑Constructive Training for the RCAFTop Aces to Acquire SGITop Aces today announced an agreement to acquire Select Global International (“SGI”)MONTREAL, June 11, 2026 (GLOBE NEWSWIRE) — Top Aces Inc. (“Top Aces”), a global leader in advanced operational air combat training, today announced an agreement to acquire Select Global International (“SGI”), a Canadian defence company with deep expertise in simulator-based fighter pilot instruction supporting the Royal Canadian Air Force (“RCAF”). Founded in 2013, SGI has built a strong reputation delivering high-fidelity synthetic training solutions for CF-18 aircrew. The company is comprised of highly experienced former CF-18 instructor pilots, many of whom have recent operational and command experience within the RCAF. The acquisition brings...

Continue reading

Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK

Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25 mg in adults living with obesity and overweight versus placebo in addition to diet and exercise Semaglutide tablets will be available as a once-daily treatment, an alternative to weekly injections for adults living with obesity or overweight with a weight-related condition, alongside diet and exercise After this approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), Novo Nordisk anticipates Wegovy® pill will be available via private prescription within weeksBagsværd, Denmark, 11 June 2026 – Wegovy® pill, the new daily weight management tablet, has been approved in the UK as an adjunct to a reduced-calorie diet and increased physical activity, offering a first-of-its-kind alternative to injectable treatments for...

Continue reading

Old National Bank Awarded Bauer Financial 5-Star Superior Rating for Financial Strength and Stability

EVANSVILLE, Ind., June 11, 2026 (GLOBE NEWSWIRE) — (NASDAQ: ONB) – Old National Bank, a wholly-owned banking subsidiary of Old National Bancorp (“Old National”), has been awarded Bauer Financials’ 5-Star “Superior” rating, the highest distinction for financial strength and stability. Bauer Financial, Inc., (“Bauer Financial”) is the nation’s leading independent bank rating firm whose 5-Star “Superior” rating recognizes institutions with exceptional financial performance, and are considered among the strongest in the country. “This recognition reinforces the disciplined way we manage our business and the trust our clients place in us each and every day,” said Jim Ryan, Chairman and CEO of Old National. “We remain focused on long-term strength, prudent risk management, and consistently delivering value for our clients and communities....

Continue reading

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

Media Release COPENHAGEN, Denmark; June 11, 2026Findings from a post-hoc subgroup analysis of the Phase 3 EPCORE® FL-1 trial reinforce fixed-duration epcoritamab in combination with rituximab and lenalidomide (R2 ) data across subgroups in this trial of relapsed or refractory (R/R) follicular lymphoma (FL) patients treated in the second-line or later setting Epcoritamab in combination with R2 demonstrated sustained efficacy with manageable safety, regardless of baseline risk factors, including those traditionally associated with higher- or lower-risk disease factors Data were presented during an oral presentation at the 2026 European Hematology Association (EHA) CongressGenmab A/S (Nasdaq: GMAB) today announced new data from a post-hoc subgroup analysis from the pivotal Phase 3 EPCORE® FL-1 trial, evaluating epcoritamab, a subcutaneous...

Continue reading

Xcel Brands Announces License Agreement for Trust. Respect. Love by Cesar Millan with EcoStrong

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) — Xcel Brands (NASDAQ: XELB), an industry-leading media and consumer products company specializing in building influencer led brands through social commerce and livestream shopping, is pleased to announce a new licensing partnership for Trust. Respect. Love by Cesar Millan with licensing partner EcoStrong for product categories that include cleaning products, odor management, shampoo and conditioners. The partnership will introduce a collection of innovative pet care, pet shampoo, and home cleaning products inspired by Cesar Millan’s philosophy that trust, respect, and love are the foundation of every meaningful relationship between pets and their owners. The collection includes environmentally safe cleaning, grooming, and odor control solutions designed to support healthier homes and happier...

Continue reading

Hotel101-Madrid once again reached 100% occupancy yesterday, June 10, 2026, with all rooms sold out significantly prior to the close of the day

Hotel101-Madrid marked its third month of operations since its opening last March 10, 2026, achieving several full occupancy performances in the recent weeks, demonstrating sustained market demand. This solidifies the continued growth in recurring room demand at the 680-room Hotel101 in Madrid as room bookings continue to surge. In just the past 30 days, Hotel101-Madrid generated over USD2.3 million from recurring room revenues alone. On June 10, 2026, Hotel101-Madrid recorded single-day room revenue exceeding USD100,000. This marks another strong day as average daily room revenues have continued to rise compared with the hotel’s first month of operations. Management believes that the Hotel101 global prototype has now been polished and calibrated and is ready to hyperscale. Management intends to accelerate the replication of the cookie...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.